Showing results (1-10 of 54) with videos related to

Sort By:
Pageof 6
Translational Lung Cancer Research|February 4, 2020
Rationale and design of a phase II trial of osimertinib as first-line treatment for elderly patients with epidermal growth factor receptor mutation-positive advanced non-small cell lung cancer (SPIRAL-0 study)Yusuke Chihara, Tadaaki Yamada, Junji Uchino, et al.
Medicine|June 8, 2018
Treatment rationale and design of the RAMNITA study: A phase II study of the efficacy of docetaxel + ramucirumab for non-small cell lung cancer with brain metastasisKeiko Tanimura, Junji Uchino, Nobuyo Tamiya, et al.
The Journal of Steroid Biochemistry and Molecular Biology|October 1, 2025
17β-estradiol (E2) increases ciliary beat frequency via membrane estrogen receptor βKouta Noriyama, Nobuhisa Todo, Nobuyo Tamiya, et al.
Cancers|March 27, 2019
Safety and Usefulness of Cryobiopsy and Stamp Cytology for the Diagnosis of Peripheral Pulmonary LesionsTatsuya Imabayashi, Junji Uchino, Akihiro Yoshimura, et al.
Internal Medicine (Tokyo, Japan)|July 19, 2022
Wild-type Transthyretin Amyloidosis with Diffuse Alveolar-septal Amyloidosis Diagnosed by a Transbronchial Lung BiopsyMasaki Ishida, Masamitsu Enomoto, Tae Hata, et al.
Medicine|June 8, 2018
Treatment rationale and design of the SPIRAL study: A phase II trial of osimertinib in elderly epidermal growth factor receptor T790M-positive nonsmall-cell lung cancer patients who progressed during prior EGFR-TKI treatmentJunji Uchino, Akira Nakao, Nobuyo Tamiya, et al.
Clinical Lung Cancer|March 26, 2019
Rationale and Design of a Phase II Trial of Osimertinib Combined With Bevacizumab in Patients With Untreated Epidermal Growth Factor Receptor-mutated Non-small-cell Lung Cancer and Malignant Pleural and/or Pericardial Effusion (SPIRAL II Study)Osamu Hiranuma, Junji Uchino, Tadaaki Yamada, et al.
Anticancer Research|December 30, 2025
Ginsenoside Rd Improves Anticancer Drug-induced Disturbance in Murine Airway Ciliary MotilityKouta Noriyama, Nobuhisa Todo, Seikou Nakamura, et al.
Biological & Pharmaceutical Bulletin|May 21, 2025
Ginsenoside Rd Activates Ciliary Beat Frequency via Estrogen Receptor β and P2X7 ReceptorKouta Noriyama, Shigekuni Hosogi, Seikou Nakamura, et al.
Cancers|March 2, 2019
Nicotine Induces Resistance to Erlotinib Therapy in Non-Small-Cell Lung Cancer Cells Treated with Serum from Human PatientsTatsuya Imabayashi, Junji Uchino, Hisayuki Osoreda, et al.
Pageof 6